Sayre Therapeutics Private Limited, a active private limited company, was established on 07 April 2015 in Somasundara Palya, Karnataka, India. Engaging in diagnostic centers & pathology labs within the trade sector, it holds CIN: U85110KA2015PTC079687. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.03 M and a paid-up capital of ₹2.88 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Shukrit Sudhir Chimote (Director), Mahendran Balachandran (Director), Sasidharan Rajesh (Director). Past directors included Vandana Subramanian, Praveenbose Sivasankaran, Mahendran Balachandran. It holds ₹36.50 Cr open charges and ₹18.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.1104, Sobha Cinnamon Apartment, Haralur Road,, Somasundara Palya, Karnataka, 560102.
U85110KA2015PTC079687
079687
07 April 2015
₹3.03 M
₹2.88 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sayre Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shukrit Sudhir Chimote | Director | 07 Apr 2015 | Current |
| Mahendran Balachandran | Director | 30 Jun 2015 | Current |
| Sasidharan Rajesh | Director | 23 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2019 | Past |
| Pramod Abcsdd | Director | 23 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 29 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sayre Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.31% increase. The company also saw a substantial improvement in profitability, with a 43.78% increase in profit. The company's net worth dipped by a decrease of 3.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sayre Therapeutics had a promoter holding of 86.44% and a public holding of 13.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹365,000,000.00
₹183,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | Axis Bank Limited | ₹18.00 Cr | Open |
| 29 Nov 2021 | Hdfc Bank Limited | ₹8.50 Cr | Open |
| 26 Jul 2021 | Others | ₹10.00 Cr | Open |
| 29 Apr 2019 | Hdfc Bank Limited | ₹6.30 Cr | Satisfied |
| 27 Dec 2017 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Sayre Therapeutics has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sayre Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sayre Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sayre Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Sayre Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 180.00 M with Charge ID 100808839 was registered on 12 Oct 2023. was completed.
The activity Sasidharan Rajesh was appointed as a Director was appointed as a Director on 23 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
A charge with Hdfc Bank Limited amounted to Rs. 85.00 M with Charge ID 100516460 was registered on 29 Nov 2021. was recorded as a recent event.
Progress on A charge registered on 29 Apr 2019 via Charge ID 100262942 with Hdfc Bank Limited was fully satisfied on 01 Sep 2021. was documented.
Bengaluru-based Sayre Therapeutics, a super- speciality pharma company, has also raised $1 million in venture-debt from InnoVen Capital.
The CIN of Sayre Therapeutics Private Limited is U85110KA2015PTC079687.
Sayre Therapeutics Private Limited is headquartered at Flat No.1104, Sobha Cinnamon Apartment, Haralur Road,, Somasundara Palya, Karnataka, 560102.
Sayre Therapeutics Private Limited was incorporated on 07 April 2015.
The current directors of Sayre Therapeutics Private Limited are
The primary industry of Sayre Therapeutics Private Limited is Trade.
Sayre Therapeutics Private Limited is unlisted.
The authorized capital of Sayre Therapeutics Private Limited is ₹3.03 M, and the paid-up capital is ₹2.88 M.
The compliance status of Sayre Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX